Dickerman J D, Bolton E, Coil J A, Chalmer B J, Jakab G J
Blood. 1979 Mar;53(3):498-503.
Prophylactic penicillin has been recommended for use in asplenic patients and postsplenectomy patients. A laboratory model using aerosolized pneumococci has been devised to test the effectiveness of prophylactic penicillin in a manner analogous to human experience. There is increased mortality, over time, in asplenic mice exposed to aerosolized type III Streptococcus pneumoniae. One hundred twenty-one male Swiss mice (mean weight 26 g) were divided into four groups: splenectomized, sham-operated, splenectomized + penicillin, and sham-operated + penicillin. After 2 wk the four groups were exposed for 30 min to an aerosolized atmosphere of 2.4 x 10(9) colony-forming units of type III S. pneumoniae using a Tri-R model A-42 airborne infection apparatus. Penicillin was given at a daily intramuscular dosage of 40,000 units procaine penicillin G beginning 2 days prior to exposure and continuing through the third day after exposure. The splenectomized and sham-operated mice given penicillin showed significantly lower mortality (p less than 0.001) than mice not given penicillin.
预防性青霉素已被推荐用于无脾患者和脾切除术后患者。一种使用雾化肺炎球菌的实验室模型已被设计出来,以类似于人类实际情况的方式测试预防性青霉素的有效性。随着时间的推移,暴露于雾化III型肺炎链球菌的无脾小鼠死亡率增加。121只雄性瑞士小鼠(平均体重26克)被分为四组:脾切除组、假手术组、脾切除+青霉素组和假手术+青霉素组。两周后,使用Tri-R模型A-42空气传播感染装置,将这四组小鼠暴露于含有2.4×10⁹个III型肺炎链球菌菌落形成单位的雾化环境中30分钟。从暴露前2天开始,每天肌肉注射40000单位普鲁卡因青霉素G,持续到暴露后第三天。给予青霉素的脾切除和假手术小鼠的死亡率显著低于未给予青霉素的小鼠(p<0.001)。